Understanding Patient Engagement Trends in TBI Clinical Research

NCT06288698 · tracked via the Priya Life Science USA tracker

Sponsor

Power Life Sciences Inc.

Phase

Observational

Started

2025-03

Last updated

2024-03-01

Condition(s) studied

TBI

Study summary

Clinical trials, specifically focused on TBI, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.

The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Ability to understand and the willingness to sign a written informed consent document * Participant must be 18 years of age or older * Confirmed diagnosis of TBI Exclusion Criteria: * Enrolled in another research study * Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study * Inability to provide written informed consent

Primary outcome measure(s)

Number of TBI patients who decide to enroll in a clinical research — 3 months
Rate of TBI patients who remain in clinical trial to trial completion — 12 months

Trial sites (1)

Facility	City	Region	Status
Power Life Sciences	San Francisco	California

More Power Life Sciences Inc. trials in the USA

Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients Starting soon

Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients Starting soon

Understanding Participation Habits Among Plaque Psoriasis Patients Starting soon

Navigating the Clinical Research Process for Lymphoma Starting soon

Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06288698 on ClinicalTrials.gov ↗ ← All trials in the USA